Invivo Therapeutics Holdings Corp.
NVIV
Revenue
0.00
0.000.00%
-Assets
9.58M
▼-3.75M▼-28.12%
3 Months ChangeLiabilities
666.00k
▼-1.09M▼-62.09%
3 Months ChangeFree Cash Flow
-3.23M
▲630.00k▲16.34%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-06
Form 8-K
ID: 0001104659-24-010941
2024-02-01
Form 8-K
ID: 0001104659-24-009146
2024-01-03
Form 8-K
ID: 0001104659-24-000868
2023-12-01
Form 8-K
ID: 0001104659-23-122862
2023-11-30
Form 8-K
ID: 0001104659-23-122271
2023-11-22
Form 8-K
ID: 0001104659-23-120778
2023-11-08
Form 10-Q
ID: 0001558370-23-018294
2023-09-01
Form 8-K
ID: 0001104659-23-097791
2023-08-09
Form 10-Q
ID: 0001558370-23-014294
2023-05-12
Form 10-Q
ID: 0001558370-23-009616